These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 12095549)

  • 1. Quality of life after curative radiotherapy in Stage I non-small-cell lung cancer.
    Langendijk JA; Aaronson NK; de Jong JM; ten Velde GP; Muller MJ; Slotman BJ; Wouters EF
    Int J Radiat Oncol Biol Phys; 2002 Jul; 53(4):847-53. PubMed ID: 12095549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective study on quality of life before and after radical radiotherapy in non-small-cell lung cancer.
    Langendijk JA; Aaronson NK; de Jong JM; ten Velde GP; Muller MJ; Lamers RJ; Slotman BJ; Wouters EF
    J Clin Oncol; 2001 Apr; 19(8):2123-33. PubMed ID: 11304764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality of life during 5 years after stereotactic radiotherapy in stage I non-small cell lung cancer.
    Ubels RJ; Mokhles S; Andrinopoulou ER; Braat C; van der Voort van Zyp NC; Aluwini S; Aerts JG; Nuyttens JJ
    Radiat Oncol; 2015 Apr; 10():98. PubMed ID: 25896787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prognostic impact of quality of life assessed with the EORTC QLQ-C30 in inoperable non-small cell lung carcinoma treated with radiotherapy.
    Langendijk H; Aaronson NK; de Jong JM; ten Velde GP; Muller MJ; Wouters M
    Radiother Oncol; 2000 Apr; 55(1):19-25. PubMed ID: 10788684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality of life after stereotactic radiotherapy for stage I non-small-cell lung cancer.
    van der Voort van Zyp NC; Prévost JB; van der Holt B; Braat C; van Klaveren RJ; Pattynama PM; Levendag PC; Nuyttens JJ
    Int J Radiat Oncol Biol Phys; 2010 May; 77(1):31-7. PubMed ID: 19864077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluating quality of life and pulmonary function of long-term survivors of non-small cell lung cancer treated with radical or postoperative radiotherapy.
    Ozturk A; Sarihan S; Ercan I; Karadag M
    Am J Clin Oncol; 2009 Feb; 32(1):65-72. PubMed ID: 19194128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term quality of life in early-stage non-small cell lung cancer patients treated with robotic stereotactic ablative radiation therapy.
    Mathieu D; Campeau MP; Bahig H; Larrivée S; Vu T; Lambert L; Lavoie C; Roberge D; Doucet R; Carrier JF; Gorgos A; Fortin B; Filion E
    Pract Radiat Oncol; 2015; 5(4):e365-73. PubMed ID: 25680997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality of life after palliative radiotherapy in non-small cell lung cancer: a prospective study.
    Langendijk JA; ten Velde GP; Aaronson NK; de Jong JM; Muller MJ; Wouters EF
    Int J Radiat Oncol Biol Phys; 2000 Apr; 47(1):149-55. PubMed ID: 10758317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pretreatment quality of life of inoperable non-small cell lung cancer patients referred for primary radiotherapy.
    Langendijk JA; Aaronson NK; ten Velde GP; de Jong JM; Muller MJ; Wouters EF
    Acta Oncol; 2000; 39(8):949-58. PubMed ID: 11207002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term quality of life in inoperable non-small cell lung cancer patients treated with conventionally fractionated compared to hyperfractionated accelerated radiotherapy - Results of the randomized CHARTWEL trial.
    Hechtner M; Krause M; König J; Appold S; Hornemann B; Singer S; Baumann M
    Radiother Oncol; 2018 Feb; 126(2):283-290. PubMed ID: 29273262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiotherapy alone for medically inoperable stage I non-small-cell lung cancer: the Duke experience.
    Sibley GS; Jamieson TA; Marks LB; Anscher MS; Prosnitz LR
    Int J Radiat Oncol Biol Phys; 1998 Jan; 40(1):149-54. PubMed ID: 9422571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypofractionated palliative radiotherapy (17 Gy per two fractions) in advanced non-small-cell lung carcinoma is comparable to standard fractionation for symptom control and survival: a national phase III trial.
    Sundstrøm S; Bremnes R; Aasebø U; Aamdal S; Hatlevoll R; Brunsvig P; Johannessen DC; Klepp O; Fayers PM; Kaasa S
    J Clin Oncol; 2004 Mar; 22(5):801-10. PubMed ID: 14990635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of pre-radiation therapy quality of life in lung cancer survival: a prospective, intention-to-treat, multicenter study.
    Nieto-Guerrero Gómez JM; Silva Vega GP; Cacicedo J; Delgado León BD; Herrero Rivera D; Praena Fernández JM; Rivin Del Campo E; Ortiz Gordillo MJ; López Guerra JL
    Clin Transl Oncol; 2020 Sep; 22(9):1635-1644. PubMed ID: 32072471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health related quality of life in locally advanced NSCLC treated with high dose radiotherapy and concurrent chemotherapy or cetuximab--pooled results from two prospective clinical trials.
    Hallqvist A; Bergman B; Nyman J
    Radiother Oncol; 2012 Jul; 104(1):39-44. PubMed ID: 22727262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. External irradiation versus external irradiation plus endobronchial brachytherapy in inoperable non-small cell lung cancer: a prospective randomized study.
    Langendijk H; de Jong J; Tjwa M; Muller M; ten Velde G; Aaronson N; Lamers R; Slotman B; Wouters M
    Radiother Oncol; 2001 Mar; 58(3):257-68. PubMed ID: 11230886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Small-volume image-guided radiotherapy using hypofractionated, coplanar, and noncoplanar multiple fields for patients with inoperable Stage I nonsmall cell lung carcinomas.
    Fukumoto S; Shirato H; Shimzu S; Ogura S; Onimaru R; Kitamura K; Yamazaki K; Miyasaka K; Nishimura M; Dosaka-Akita H
    Cancer; 2002 Oct; 95(7):1546-53. PubMed ID: 12237924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality of life assessment in advanced non-small-cell lung cancer patients undergoing an accelerated radiotherapy regimen: report of ECOG study 4593. Eastern Cooperative Oncology Group.
    Auchter RM; Scholtens D; Adak S; Wagner H; Cella DF; Mehta MP
    Int J Radiat Oncol Biol Phys; 2001 Aug; 50(5):1199-206. PubMed ID: 11483329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-dose radiotherapy or concurrent chemo-radiation in lung cancer patients only induces a temporary, reversible decline in QoL.
    Pijls-Johannesma M; Houben R; Boersma L; Grutters J; Seghers K; Lambin P; Wanders R; De Ruysscher D
    Radiother Oncol; 2009 Jun; 91(3):443-8. PubMed ID: 19297049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of lung cancer response after nonoperative therapy: tumor diameter, bidimensional product, and volume. A serial CT scan-based study.
    Werner-Wasik M; Xiao Y; Pequignot E; Curran WJ; Hauck W
    Int J Radiat Oncol Biol Phys; 2001 Sep; 51(1):56-61. PubMed ID: 11516851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elective nodal failures are uncommon in medically inoperable patients with Stage I non-small-cell lung carcinoma treated with limited radiotherapy fields.
    Bradley JD; Wahab S; Lockett MA; Perez CA; Purdy JA
    Int J Radiat Oncol Biol Phys; 2003 Jun; 56(2):342-7. PubMed ID: 12738307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.